NCT01487837View on ClinicalTrials.gov

Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Blood Coagulation DisordersHemorrhage
Interventions
DRUG

Human fibrinogen concentrate

Administration of human fibrinogen concentrate (30 mg / kg bw) over 15 min Repetition if hourly intraoperative ROTEM measurements revealed hypofibrinogenemia according to treatment group definition

Trial Locations (1)

8032

Zurich University Children's Hospital, Zurich

All Listed Sponsors
lead

University Children's Hospital, Zurich

OTHER

NCT01487837 - Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study. | Biotech Hunter | Biotech Hunter